Kingworld Medicines

Introduction to Kingworld Medicines Group (01110.HK) Kingworld Medicines Group was founded in Shenzhen in 1996 and listed on the Main Board of the Hong Kong Stock Exchange in 2010 with stock code 01110. For over two decades, Kingworld Medicines Group has been consumer-oriented, working with partners to gradually build a comprehensive upstream and downstream supply chain system for the pharmaceutical and health industry. Its business currently covers more than 34 provinces and cities nationwide, with 26 subsidiaries at various levels and 6 associated companies established in the mainland and Hong Kong and Macao regions. Its subsidiary Shenzhen Kingworld Medicines is mainly engaged in the agency of imported branded pharmaceuticals and health products in China, distributing and representing a variety of famous brand health products such as Hong Kong Kyoto Nin Jiom Pei Pa Koa, American Culturelle probiotics, Japanese Seirogan, Kingworld Imada Red Flower Oil, Mentholatum series, Norwegian LifelineCare fish oil, American CARMEX, and the Global Slim series, building a bridge of health for consumers and providing high-end logistics management services, B2C trade services, data services and supply chain financial services for major core pharmaceutical and health suppliers, manufacturers and distributors in *, thereby establishing a renowned agency position in the industry. It has successively won numerous honors such as Shenzhen Top 50 Private Enterprises, "Top 20 Pharmaceutical Wholesale Enterprises in Guangdong Province in 30 Years of Reform and Opening Up", "AAA Credit Rating Enterprise in China's Health Industry", "Hong Kong Outstanding Enterprise", "Shenzhen Time-honored Brand", and China Top 100 Importers of Pharmaceutical and Health Products. Adapting to the new normal of consumption upgrading, Kingworld integrates online new marketing models with offline channels to serve consumers more efficiently and provide them with intelligent family health management professional services, comprehensively building Kingworld's online and offline new retail ecosystem. In 2015, Kingworld Medicines Group acquired a 55% stake in Dongdixin Technology, entering the global medical and health electronic products market and expanding into the big health field. In addition, it established a strategic cooperation with Sinopharm Capital to integrate resources of both parties to become bigger and stronger. In the future, Kingworld Medicines Group will continue to uphold the corporate mission of "benefiting the world and nourishing all beings", committed to becoming a well-known domestic and * full-chain and omni-channel supply chain enterprise for big health product services, based on consumers, market demand-oriented, and working with partners to actively build an information-sharing, mutually beneficial and win-win supply chain ecosystem. We will provide you with a comprehensive compensation and benefits system: 1. 5-day, 8-hour work system; 2. Social insurance and housing provident fund purchased upon entry in accordance with national regulations; 3. Paid holidays such as statutory holidays, marriage leave, maternity leave, etc. in accordance with national regulations; 4. Paid annual leave (5-10 days); 5. One free full-body checkup per year; 6. One unified salary adjustment per year, and outstanding employees can also apply for special salary increases; 7. Holiday gifts and high-temperature subsidies; 8. Good training and development opportunities; 9. Those who meet Shenzhen household registration transfer standards can apply for Shenzhen settlement procedures. We warmly welcome you to join Kingworld, with broader development space, more competitive compensation and benefits, and a higher happiness index.